HighVista Strategies LLC

CIK

1335325

City

BOSTON

State / Country

MA

Stock

ELVN — Enliven Therapeutics, Inc.

Top Portfolio Positions

154 positions · $359,474,418 total · as of Mar 31, 2026

Ticker	Company	Shares	Value (USD)	% of Portfolio	Open
DBC	Invesco DB Commodity Index Tracking Fund	1,057,238	$30,607,040	8.51%
ABVX	Abivax S.A. Healthcare	113,254	$12,610,832	3.51%
PRAX	Praxis Precision Medicines, Inc. Healthcare	26,323	$8,481,007	2.36%
COGT	Cogent Biosciences, Inc. Healthcare	197,051	$7,584,492	2.11%
SYRE	Spyre Therapeutics, Inc. Healthcare	146,264	$7,377,556	2.05%
PCVX	Vaxcyte, Inc. Healthcare	124,647	$7,243,237	2.01%
RVMD	Revolution Medicines, Inc. Healthcare	69,309	$6,740,300	1.88%
TERN	Terns Pharmaceuticals, Inc. Healthcare	114,307	$6,026,265	1.68%
GPCR	Structure Therapeutics Inc. Healthcare	123,909	$5,972,413	1.66%
NUVL	Nuvalent, Inc. Healthcare	56,602	$5,798,874	1.61%

Portfolio Trend

25 quarters · across all stocks

Holdings in ELVN

Compact Export CSV

Shares Held

Position Value (USD)

12 quarters on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,865,598	73,102	-11.4%	Shares	Sole	2026-05-15
2025-12-31	$1,271,054	82,536	-68.1%	Shares	Sole	2026-02-17
2025-09-30	$5,304,493	259,135	+83.1%	Shares	Sole	2025-11-14
2025-06-30	$2,838,810	141,516	+25.8%	Shares	Sole	2025-08-14
2025-03-31	$2,213,193	112,459	0.0%	Shares	Sole	2025-05-15
2024-12-31	$2,530,327	112,459	0.0%	Shares	Sole	2025-02-14
2024-09-30	$2,872,202	112,459	-6.1%	Shares	Sole	2024-11-14
2024-06-30	$2,799,468	119,789	-5.6%	Shares	Sole	2024-08-14
2024-03-31	$2,231,361	126,854	-7.6%	Shares	Sole	2024-05-15
2023-12-31	$1,899,415	137,241	+10.2%	Shares	Sole	2024-02-14
2023-09-30	$1,701,858	124,587	+2.9%	Shares	Sole	2023-11-14
2023-06-30	$2,471,099	121,073	—	Shares	Sole	2023-08-14
No 13F history on record for this holder in this stock.